Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 20
Titolo Data di pubblicazione Autore(i) File
Effect of treatment with amifostine in patients with myelodisplastic syndromes on clinical outcome and apoptosis in bone marrow 1-gen-2001 Pitini, Vincenzo; Arrigo, Carmela; Aloi, Graziella; Micali, Giuseppe; Azzarello, D; Righi, Maria; LA TORRE, Francesco
Myelodysplastic syndrome/acute myelogenous leukaemia after adjuvant chemotherapy with pyrimidine anti-metabolites in three patients 1-gen-2001 Pitini, Vincenzo; Arrigo, Carmela; Aloi, Graziella; Righi, Maria; Falduto, M; Teti, Diana
Thalidomide treatment of relapsed multiple myeloma patients and changes in circulating VEGF and bFGF 1-gen-2002 Pitini, Vincenzo; Teti, Diana; Arrigo, Carmela; Aloi, G.
Serum concentration of cardiac Troponin T in patients with hypereosinophilic syndrome treated with imatinib is predictive of adverse outcomes 1-gen-2003 Pitini, Vincenzo; Arrigo, Carmela; Azzarello, D; LA GATTUTA, G; Amata, C; Righi, Maria; Coglitore, Sebastiano
Response to STI571 in chronic myelomonocytic leukemia with platelet derived growth factor beta receptor involvement: a new case report 1-gen-2003 Pitini, Vincenzo; Arrigo, Carmela; Teti, Diana; Barresi, Gaetano; Righi, Maria; Alo, G.
Fatal delayed diagnosis in a patient with falciparum malaria 1-gen-2004 Pitini, Vincenzo; Sturniolo, Giuseppe; Cascio, Antonio; Arrigo, Carmela
Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome with abnormal T cells: a case report 1-gen-2004 Pitini, Vincenzo; Teti, Diana; Arrigo, Carmela; Righi, Maria
Surgical treatment for congestive heart failure with autologous adult stem cell transplantation 1-gen-2006 Pitini, Vincenzo; Altavilla, Giuseppe; Arrigo, Carmela
An acute-leukaemia-like picture due to breast carcinoma cells. 1-gen-2006 Pitini, Vincenzo; Arrigo, Carmela; Altavilla, Giuseppe
Salvage therapy for primary central nervous system lymphoma with Y-90-Ibritumomab and Temozolomide 1-gen-2007 Pitini, Vincenzo; Baldari, Sergio; Altavilla, Giuseppe; Arrigo, Carmela; Naro, claudia francesca; Perniciaro, F.
Severe pulmonary complications after bortezomib treatment for multiple myeloma: An unrecognized pulmonary vasculitis? 1-gen-2007 Pitini, Vincenzo; Arrigo, Carmela; Altavilla, Giuseppe; Naro, C.
CLINICAL ACTIVITY OF BORTEZOMIB IN RELAPSED OR REFRACTORY GASTRIC MARGINAL ZONE B-CELL LYMPHOMA OF MALT TYPE 1-gen-2008 Spadaro, P; Pitini, Vincenzo; Toscano, G; Soto, Hj; Ingemi, Mc; Dottore, G; Arrigo, Carmela; Buda, Carmelo
Extramedullary plasmacytoma presented as a non-functional invasive pituitary macro-adenoma. 1-gen-2008 Pitini, Vincenzo; Arrigo, Carmela; Alafaci, Concetta; Altavilla, Giuseppe
ERLOTINIB IN A PATIENT WITH ACUTE MYELOGENOUS LEUKEMIA AND CONCOMITANT NON-SMALL-CELL LUNG CANCER 1-gen-2008 Pitini, Vincenzo; Arrigo, Carmela; Altavilla, Giuseppe
Amplification and overexpression of the PSMB5 gene contribute to Bortezomib resistance in re-treatment of patients with Multiple Myeloma 1-gen-2009 Altavilla, Giuseppe; Arrigo, Carmela; Sauta, M. G.; Galletti, G.; Gnani, Alessandro; Pettineo, G.; Buemi, B.; Pitini, Vincenzo
Myelodysplastic syndrome appearing during imatinib mesylate therapy in a patient with GIST 1-gen-2009 Pitini, Vincenzo; Arrigo, Carmela; Sauta, Mg; Altavilla, Giuseppe
DASATINIB INDUCES A RESPONSE IN CHRONIC LYMPHOCYTIC LEUKEMIA 1-gen-2009 Pitini, Vincenzo; Arrigo, Carmela; Altavilla, Giuseppe
HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapy. 1-gen-2010 Pitini, Vincenzo; Sturniolo, Giuseppe; Arrigo, Carmela; Leonardi, Maria Silvana; Pino, S; Altavilla, Giuseppe
How cells respond to interferons. 1-gen-2010 Pitini, Vincenzo; Arrigo, Carmela; Altavilla, Giuseppe
Interferon Alpha Has a Strong Anti-tumor Effect in Philadelphia-negative Myeloproliferative Neoplasms 1-gen-2019 Mondello, P.; Di Mirto, C.; Cuzzocrea, S.; Arrigo, C.; Mian, M.; Pitini, V.
Mostrati risultati da 1 a 20 di 20
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile